← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2019Last known activity
Jul 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (5)
- NCT06212336CollaboratorPhase 2/Phase 3Jul 1, 2024
- NCT04907682CollaboratorPhase 2Jul 30, 2021
- NCT04907682Overall official - principal investigatorPhase 2Jul 30, 2021
- NCT03944317Lead sponsorN/AJun 1, 2019
- NCT03944317Reponsible party - principal investigatorN/AJun 1, 2019
Details
- Last known activity
- Jul 1, 2024